CYH - Community Health Systems, Inc.
NYSE
->
Healthcare
->
Medical Care Facilities
Franklin,
United States
Type: Equity
CYH price evolution
CYH
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $39 | $48 | $38 | |
| Short term investments | ||||
| Net receivables | $2189 | $2195 | $2194 | $2231 |
| Inventory | $311 | $337 | $329 | $328 |
| Total current assets | $3108 | $3199 | $3175 | $3208 |
| Long term investments | ||||
| Property, plant & equipment | $5579 | $5222 | $5219 | $5207 |
| Goodwill & intangible assets | $3972 | $3957 | $3958 | |
| Total noncurrent assets | $11212 | $11242 | $11247 | |
| Total investments | ||||
| Total assets | $13905 | $14411 | $14417 | $14455 |
| Current liabilities | ||||
| Accounts payable | $842 | $896 | $941 | $912 |
| Deferred revenue | ||||
| Short long term debt | $141 | $149 | $145 | |
| Total current liabilities | $2126 | $2172 | $2136 | $2142 |
| Long term debt | $11467 | $12046 | $12079 | $12029 |
| Total noncurrent liabilities | $13118 | $13159 | $13137 | |
| Total debt | $12187 | $12228 | $12174 | |
| Total liabilities | $15728 | $15290 | $15295 | $15279 |
| Shareholders' equity | ||||
| Retained earnings | -$4010 | -$3619 | -$3605 | -$3564 |
| Other shareholder equity | -$8 | -$13 | -$16 | -$14 |
| Total shareholder equity | -$1441 | -$1428 | -$1392 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $38 | $118 | $507 | $1676 |
| Short term investments | ||||
| Net receivables | $2231 | $2137 | $2062 | $1927 |
| Inventory | $328 | $353 | $355 | $335 |
| Total current assets | $3208 | $3082 | $3479 | $4510 |
| Long term investments | $190 | |||
| Property, plant & equipment | $5207 | $6103 | $5553 | $5322 |
| Goodwill & intangible assets | $3958 | $4166 | $4219 | $4219 |
| Total noncurrent assets | $11247 | $11587 | $11738 | $11496 |
| Total investments | ||||
| Total assets | $14455 | $14669 | $15217 | $16006 |
| Current liabilities | ||||
| Accounts payable | $912 | $773 | $830 | $783 |
| Deferred revenue | ||||
| Short long term debt | $145 | $169 | $178 | $265 |
| Total current liabilities | $2142 | $2186 | $2364 | $2815 |
| Long term debt | $12029 | $11614 | $12644 | $12617 |
| Total noncurrent liabilities | $13137 | $13217 | $13663 | $14245 |
| Total debt | $12174 | $12388 | $12822 | $12882 |
| Total liabilities | $15279 | $16036 | $16027 | $17060 |
| Shareholders' equity | ||||
| Retained earnings | -$3564 | -$3431 | -$3477 | -$3707 |
| Other shareholder equity | -$14 | -$2 | -$14 | -$13 |
| Total shareholder equity | -$1392 | -$1367 | -$1372 | -$1625 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $3140 | $3140 | $3182 | |
| Cost of revenue | $483 | $487 | $494 | |
| Gross Profit | $2657 | $2653 | $2688 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $2211 | $2213 | $2239 | |
| Total operating expenses | $2409 | $2405 | $2439 | |
| Operating income | $248 | $248 | $249 | |
| Income from continuing operations | ||||
| EBIT | $227 | $198 | $363 | |
| Income tax expense | $24 | $28 | $107 | |
| Interest expense | $216 | $211 | $209 | |
| Net income | ||||
| Net income | -$13 | -$41 | $47 | |
| Income (for common shares) | -$13 | -$41 | $47 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $12490 | $12211 | $12368 | $11789 |
| Cost of revenue | $1993 | $1975 | $2042 | $1963 |
| Gross Profit | $10497 | $10236 | $10326 | $9826 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $8803 | $8666 | $8200 | $8368 |
| Total operating expenses | $9627 | $9344 | $8900 | $8652 |
| Operating income | $870 | $892 | $1426 | $1174 |
| Income from continuing operations | ||||
| EBIT | $888 | $1074 | $1246 | $1357 |
| Income tax expense | $191 | $170 | $131 | -$185 |
| Interest expense | $830 | $858 | $885 | $1031 |
| Net income | ||||
| Net income | -$133 | $46 | $230 | $511 |
| Income (for common shares) | -$133 | $46 | $230 | $511 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | -$13 | -$41 | $47 | |
| Operating activities | ||||
| Depreciation | $126 | $115 | $121 | |
| Business acquisitions & disposals | -$5 | $303 | ||
| Stock-based compensation | $2 | $6 | $6 | |
| Total cash flows from operations | $101 | $96 | $90 | |
| Investing activities | ||||
| Capital expenditures | -$85 | -$92 | -$109 | |
| Investments | -$23 | -$2 | -$14 | |
| Total cash flows from investing | -$132 | -$108 | -$99 | $180 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$2 | |||
| Net borrowings | $33 | $65 | -$291 | |
| Total cash flows from financing | -$137 | -$2 | $13 | -$323 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$5 | -$9 | $10 | -$53 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$133 | $46 | $230 | $511 |
| Operating activities | ||||
| Depreciation | $505 | $534 | $540 | $558 |
| Business acquisitions & disposals | $383 | $182 | $117 | $647 |
| Stock-based compensation | $22 | $20 | $25 | $13 |
| Total cash flows from operations | $210 | $300 | -$131 | $2178 |
| Investing activities | ||||
| Capital expenditures | -$439 | -$377 | -$459 | -$436 |
| Investments | $30 | -$64 | -$182 | -$34 |
| Total cash flows from investing | -$26 | -$259 | -$524 | $177 |
| Financing activities | ||||
| Dividends paid | -$116 | |||
| Sale and purchase of stock | -$4 | -$8 | -$5 | -$1 |
| Net borrowings | -$123 | -$305 | -$369 | -$794 |
| Total cash flows from financing | -$264 | -$430 | -$514 | -$895 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$80 | -$389 | -$1169 | $1460 |
News
Fundamentals
| Market cap | $362.62M |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 138.94M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | -10.98 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.46 |
| Quick ratio | 1.32 |